Ore Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ore Pharmaceuticals Inc.

ORXE 0.193

+1.8%

Aug 18 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (26)	2/20/2009 12:07:13 PM
From: Mike McFarland	of 50

Strategic Re-alignment Continues - Fourth Quarter 2008 Financial Results Reported phx.corporate-ir.net; December 31, 2008 cash was $10.8M with and 14 employees now. SEC filings include SC 13G/A GENE LOGIC INC(RENAISSANCE TECHNOLOGIES LLC) 02/13/09 SC 13G GENE LOGIC INC(DIMENSIONAL FUND ADVISORS INC) 02/09/09 SC 13G/A GENE LOGIC INC(DIMENSIONAL FUND ADVISORS INC) 02/09/09 A quick glance looks like DFA is out while hedge fund quant type guy James H. Simons is in for 7.5%

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next